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The establishment of thymus-derived (T) 1 and bone marrow-derived (B) cell 
cooperative interactions in humoral immune responses has led to a  reappraisal 
of the conceptual and experimental approach to the study of tolerance. From an 
early point of relative confusion about  the  target cell for tolerance induction, 
the very elegant experiments of Chiller et al.  (1, reviewed in reference 2) have 
clearly elucidated the critical kinetic and dose threshold differences for tolerance 
induction in T  and B  lymphocytes insofar as thymus-dependent  antigens  are 
concerned. 
Nonetheless, it is still not known how both types of immunocompetent  ceils are 
rendered specifically unresponsive. A  great deal of this confusion stems from appar- 
ently contradictory observations reported from  studies of  the  frequency  of specific 
antigen-binding cells in  normal,  immune,  and  tolerant  animals.  This  is  a  crucial 
issue since on it rests the correct interpretation concerning the fate of tolerant cells. 
Some  investigators  have  observed  dearly  diminished  numbers  of  such  antibody- 
forming cell precursors in tolerant animals (3, 4), whereas others have demonstrated 
specific antigen-binding cells present in relatively normal numbers  in  such  animals 
(5-8).  Reasonable  explanations  for  these  differences  concern  the  different  target 
cells involved in the various systems studied, the degree of specific tolerance existing 
at the time cells are examined, and the affinity for the antigen of the target cell popu- 
lation. 
For this and related reasons, a  model where tolerance is more or less restricted to 
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the  B  cell  population may be more ideally  suited  to  elucidation  of some  of  these 
problems. This is particularly true since the immunoglobulin nature of B cell receptors 
is  now  well  established  and  increasing  sophistication  in  the  knowledge  of antigen 
binding and movement of these receptors is being obtained (9). Since the threshold of 
tolerance induction in T  cells is considerably lower than it is in B cells (1, 2), at least 
insofar as protein antigens are concerned, it is difficult  to obtain a  selective B  cell 
tolerance in vivo once the T  cells  have already been  tolerized.  Recently, however, 
several  investigators  have reported  the successful  induction  of true  hapten-specific 
tolerance in vivo which may, indeed, reflect such a state of restricted B cell tolerance 
(4,  10-12). The model of 2,4-dinitrophenyl  (DNP)-specific tolerance which we have 
previously described  in  inbred  guinea pigs  (4),  involved  treatment  of guinea  pigs 
with a  "nonimmunogenic" DNP conjugate of the copolymer of 9-glutamic acid and 
D-lysine  (D-GL). After treatment with DNP-D-GL such guinea pigs manifested pro- 
found DNP-specific tolerance as reflected by their inability to respond to a challenge 
with  the  immunogenic  conjugate,  DNP-ovalbumin  (OVA).  The  tolerant  state  in 
this model appears to be expressed  predominantly in the population of DNP-specific 
antibody-forming cell  precursors,  and  in  this  sense  has  been  interpreted  by us  to 
reflect a  central mechanism (4, reviewed in reference  13). More recent studies have 
demonstrated a preferential depression of the high affinity antibody response in this 
model (14). 
The present studies were undertaken  to establish  conditions for induction of 
DNP-specific tolerance with DNP-D-GL in inbred mice. A unique feature of this 
tolerance model in guinea pigs was the relative ease with which tolerance could 
be induced in an animal previously primed to DNP. It was of particular interest, 
therefore,  to obtain DNP-specific tolerance in an adoptive transfer  system in 
mice. Such a model would offer considerable advantage in further experimenta- 
tion designed to approach questions concerning the existence and mechanism of 
intracellular events responsible for the tolerant state. In the experiments  herein, 
we present data on various parameters of tolerance induction in such an  adop- 
tive  transfer  system and  also describe  conditions for tolerance induction  with 
DNP-D-GL in vitro. Utilizing this system, we have found that the tolerant  state 
is not broken by serial adoptive cell transfer and, moreover, that such  observa- 
tions do not reflect carry-over of tolerogen. The evidence presented  provides  a 
forceful argument  for the  concept of central  tolerance  in B  cells  as reflecting 
sub- or intracellular inhibitory events. 
Materials and Methods 
Proteins and Chemical Reagents.--The copolymers of n-glutamic acid and n-lysine (D-GL) 
and L-glutamic acid and L-lysine (L-GL)  were obtained from Pilot Chemicals, Inc., Watertown, 
Mass. Both isomers had an average molecular weight of 115,000 and a ratio of G:L of 60:40. 
Keyhole limpet  hemocyanin  (KLtt)  was purchased  from Pacific Bio-Marine  Supply  Co., 
Venice, Calif. Hen ovalbumin (OVA) 5 times reerystallized and bovine gamma globulin (BGG) 
were obtained from Pentex Biochemical, Kankakee, Ill. All other chemical reagents used were, 
in general, identical with those described in previous related studies (15). 
ttapten-Carrler Conjugates.--The following DNP conjugates were prepared as previously 1406  TOLERANCE IN"  B  LYMPHOCYTES 
described  (15, 16) : DNPg-KLH, DNP32-BGG, DNPs-OVA, and  DNPz0-L-GL. The prepara- 
tion of DNPzz-n-GL has been described in detail elsewhere  (4). Subscripts refer to the average 
number of moles of DNP per mole of carrier. 
Animals.--Mice  of the inbred lines BALB/c and A/J were obtained from Jackson Memorial 
Laboratory, Bar Harbor, Maine. All mice were used at 8-12 wk of age. 
Adoptive Transfer System.--A/J mice, 8-12 wk of age, received primary immunization with 
100 #g of DNP-KLH emulsified  in complete Freund's adjuvant  (CFA) intraperitoneaUy. At 
various times (1-3 months)  thereafter, these DNP-KLH-primed mice were killed and their 
spleens  removed. Single-cell  suspensions  in minimal essential medium  (MEM)  (Eagle) were 
prepared, washed, and transferred intravenously or intraperitoneally to syngeneic, irradiated 
(450-500  R) A/J recipients. In general, the tolerogen was administered intraperitoneally in 
saline immediately after cell transfer. Secondary antigen challenge with DNP-KLH in saline 
was  performed  intraperitoneally  3  days  later.  All mice were  bled  7 days  after  secondary 
challenge from the retroorbital plexus and serum anti-DNP antibody levels were determined 
as described below.  Modifications of this general adoptive transfer scheme are described in 
appropriate sections in Results. 
Measurement of A nti-DNP A ntibodies.--Serum anti-DNP antibody levels were determined 
by a  modified  Farr technique  (17, 18)  using  3H-labeled DNP+amino-N-caproic acid  (15). 
Using standard  curves constructed for individual mouse strains in a  manner identical with 
that described previously for inbred guinea pigs (15), percentage of binding was converted into 
amount of anti-DNP antibody in micrograms per milliliter of serum. 
Statistical Analysis.--Serum  antibody levels were logarithmically transformed mad means 
and standard errors calculated. Group comparisons were made employing Student's t test. In 
those mice in which no specific antigen binding could be detected in the serum, a value of 0.01 
~zg/ml was arbitrarily assigned  to allow logarithmic transformation of the data. 
RESULTS 
Specific Suppression of Anti-DNP Antibody Production in BALB/c Mice As a 
Result of Administration of DNP-D  -GL.-- 
When DNP-o-GL  treatment precedes primary immunization:  Normal  BALB/c mice re- 
ceived a  series  of injections of 200 #g of DNP-D-GL intrapefitoneally in saline daily for 3 
successive days. Control mice received saline injections during this period. 1 wk later, all mice 
were primarily immunized with DNP-KLH  (500 #g intraperitoneally in saline daily for 3 
successive  days).  This was followed 14 days thereafter  (day 0)  by secondary immunization 
with 500 ~g of DNP-KLH intraperitoneally in saline.  All animals were bled on days 0 and 7 
and determinations of serum anti-DNP antibody levels were made. 
As shown in Fig. 1, control mice which had received pretreatment with saline 
alone  developed  primary  anti-DNP  antibody  responses  to  DNP-KLH,  as 
evidenced by antibody levels on day 0,  and  manifested very brisk  anamnestic 
anti-DNP responses by day 7 after secondary challenge. In contrast, the synthe- 
sis of anti-DNP  antibodies was markedly suppressed in mice which had received 
pretreatment  with DNP-D-GL. This was true both for the primary response, as 
evidenced by  the  absence  of detectable  anti-DNP  antibody  on day 0,  and  for 
anamnestic responses to the secondary challenge with DNP-KLH. 
When DNP-D-GL is administered as an intervening treatment between primary and secondary 
immunization:  BALB/c mice were given a primary immunization course consisting of 501)/zg 
daily of DNP-KLH intraperitoneally in saline.  1 wk later, one group of these mice received an DAVID H. KATZ,  TOSItIYUKI tIAMAOKA,  BARU~ BENACERRAF  1407 
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Fro. 1.  Specific suppression of anti-DNP antibody production in BALB/c mice as a  result 
of administration of DNP-I)-GL before primary immunization. Normal BALB/c mice received 
a series of injections of 200 #g of aqueous DNP-D-GL intraperitoneally (i.p.) daily for 3 suc- 
cessive days. Control mice received saline injections during this period. 1 wk later, all mice 
were primarily immunized with DNP-KLH (500 #g i.p. in saline daily for 3 successive  days). 
This was followed  14  days thereafter (day 0)  by secondary immunization with 500  /.Lg of 
aqueous  DNP-K_LH  i.p. Serum  anti-DNI'  antibody  concentrations just  before  secondary 
challenge and on day 7 are illustrated. Numbers in parentheses refer to the number of animals 
in the given groups. Statistical comparison of the responses of untreated  and DNP-D-GL- 
treated animals yielded a P  value of 0.001 >  P. 
intervening series of injections of 200 #g of DNP-~)-GL  intraperitoneally in saline daily for 3 
successive  days. A control group received no intervening treatment. 2 wk  later  (day 0)  all 
mice received a secondary immunization with 500 #g of DNP-KLH intraperitoneally in saline. 
The results are presented graphically in Fig. 2. 
Mice  which  received no  intervening treatment  displayed normal  levels of 
anti-DNP antibodies 3 wk after primary immunization (day 0) and developed 
sharp anamnestic anti-DNP responses by day 7 after secondary challenge. On the 
other hand, mice which had received intervening injections of DNP-D-GL had 
no detectable anti-DNP  antibody on day 0  and were incapable of mounting 
secondary anti-DNP responses. 
The above experiments demonstrate in inbred mice precisely what  we re- 
ported earlier in  inbred  guinea  pigs  (4),  namely,  that  administration  of an 
appropriate dose of a  DNP  conjugate of a  nonimmunogenic carrier molecule 
(D-GL) results in profound DNP-specific tolerance. This is true irrespective of 
whether DNP-D-GL is  administered  to  a  normal  animal  before primary im- 
munization,  or  to  a  previously primed  mouse  in  which  anti-DNP  antibody 1408  TOLERANCE IN  B  LYMPHOCYTES 
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FIG. 2.  Specific suppression of anti-DNP antibody production in BALB/c mice  as a result 
of administration of DNP-D-GL as an intervening treatment between primary and secondary 
immunization.  I wk after primary immunization with DNP-KLH (500 pg i.p. daily for 3 
successive days), one group of BALB/c mice received an intervening series of injections of 
DNP-D-GL (200/zg i.p. daily for 3 successive days). A control group of primed mice received 
saline. 2 wk later  (day 0) all mice were secondarily challenged with 500/zg  of DNP-KLH 
i.p. Serum anti-DNP antibody concentrations just before secondary challenge and on day 7 are 
illustrated. Numbers in parentheses refer to the number of animals in the given groups. 
Statistical  comparison of  the  responses of  untreated  and  DNP-D-GL-treated  animals 
yielded a P value of 0.001 >  P. 
production has already been induced. The latter point is illustrated even more 
forcefully in the adoptive transfer experiments described below. 
Induction  of DNP-Specific  Tolerance with  DNP-D-GL  in  an  Adoptive  Cell 
Transfer System in A  Strain Mice.--A somewhat unique feature of the DNP- 
specific tolerance induced by DNP-I~-GL is  the relative ease with which  the 
tolerant state  can be  established in a  previously immunized animal (4,  and 
preceding experiments). This provides a potential advantage over other models 
of tolerance since delineation of intracellular  events in this phenomenon requires 
sufficient quantities of specific cells for any such study to be meaningful. In this 
and subsequent sections, we describe experiments in which we have established 
conditions for  induction of  DNP-specific  tolerance  in  an  adoptive  transfer 
system utilizing DNP-KLH-primed mouse spleen cells. 
In the prototype experiment (Table I), 50 X 106 spleen cells from A/J donor mice, which 
had been primed with 100 #g of DNP-KLH in CFA 46 day-s  earlier, were injected intravenously 
into individual syngeneic, irradiated  (500 12) recipients in two groups (A and B). Recipients 
in two other groups (C and D) were injected with 50 X 106 spleen cells  from identically primed 
donors which had also been treated with 1.0 mg of aqueous DNP-I)-GL intraperitoneally 7 days DAVID  H.  KATZ,  TOSHIYUKI  HAMAOKA,  BARUJ  BENACERRAF  1409 
TABLE  I 
Induction  of DNP-Specific Tolerance in Adoptivdy  Transferred  DNP-KLIt-Primed A  Strain 
Spleen  Cells by the Administration of DNP-~-GL 
Group 
Protocol*  No. of  Anti-DNP antibody~ 
Treatment  of donors of  Treatment  of recipients of  recipients  Day 7 after secondary 
DNP-KLH-primed cells  DNP-KLH-primed cells  challenge 
ug/mt 
A  None  None  10  424.8  (1.21) 
B  "  500 ~g DNP-D-GL  10  0.02  (1.50) 
C  1.0 mg DNP-D-GL i.p. 7  None  10  28.2  (1.34) 
days before sacrifice 
D  "  "  500/zg DNP-B-GL  10  0.01  (1.0) 
* Irradiated (500 R) A/J mice were injected intravenously with spleen cells (50)<  106/ 
recipient) from syngeneic donor mice which had been primed with 100/zg of DNP-KLH in 
CFA 46 days earlier (groups A and B). Recipient mice in groups C and D were injected with 
spleen cells from donors which had been identically primed with DNP-KLH but also treated 
with  1.0 mg of aqueous DNP-D-GL intraperitoneally  7 days before sacrifice. Immediately 
after  transfer, recipients were either treated  with 500/zg  of aqueous DNP-~)-GL intraperi- 
toneally (groups B and D) or not treated (groups A and C). 3 days later, all mice were second- 
arily challenged with 100/zg of DNP-KLH intraperitoneally in saline. 
The data are expressed as geometric means of serum anti-DNP antibody levels 7 days 
after secondary challenge. Numbers in parentheses represent standard  errors. A comparison 
of geometric mean antibody levels gave the following results. Comparison of group A with 
group B and group C with group D yielded _P values of 0.001 >  P in both cases. Comparison 
of group A with group C yielded a P value of 0.001 >  P. 
before sacrifice. Immediately after cell transfer, recipients were either treated with 500 #g of 
aqueous DNP-D-GL intraperitoneally  (groups B and D)  or not treated  (groups A and C). 
3 days later, all animals received secondary challenge with 100/~g of DNP-KLH intraperi- 
toneally in saline and were bled 7 days thereafter. 
Two points are noteworthy about the data presented in Table I. First, the 
results  of  groups  A  and B  illustrate the  virtual  abrogation of  the  adoptive 
secondary anti-DNP response to DNP-KLH by the administration of DNP-D- 
GL to recipient mice. Second, the striking suppression of anti-DNP responses in 
recipients of cells from DNP-KLH-primed donors which had been treated with 
one dose of DNP-D-GL manifests the profound nature of the tolerogenic effect of 
this  nonimmunogenic substance,  since  these  donors  were  immunized with 
DNP-KLH in complete adjuvant. Moreover, it is of considerable importance 
that  the  tolerant state  was  still expressed  after  adoptive transfer  (group  C) 
since this is not the  case in some models of tolerance in which this has been 
studied (19--22).  The latter point will be approached in greater detail in a sub- 
sequent section below. 
Experiments were  also carried out  to  characterize  other parameters of  the 
adoptive transfer tolerance model. In one experiment (not shown), the effective 
period of tolerance induction was studied by administering  200/zg of DNP-D-GL 1410  TOLERANCE  IN  13  LYMPIIOCYTES 
to recipients  immediately  after  adoptive  transfer  of DNP-KLH-primed  ceils, 
and  then  challenging  groups  of recipients  with  DNP-KLH  at  various  times 
(1, 6, 24, 48, or 72 hr) thereafter.  Clearly, maximal tolerization occurred in all 
treated  recipients  irrespective  of the  time interval  between  administration  of 
DNP-D-GL and challenge with DNP-KLH. A final preliminary experiment was 
performed to determine the dose relationship of DNP-D-GL to tolerance induc- 
tion. 
Spleen ceils from A/J mice primed with DNP-KLH 30 days earlier were injected intra- 
peritoneally  (50)<  10 ~ cells per recipient) into irradiated  (450 R), syngeneic recipients. Im- 
mediately after cell transfer,  groups of recipients were either treated  with varying doses of 
aqueous DNP-D-GL intraperitoneally,  or were not treated.  3 days later,  all mice were sec- 
ondarily challenged intraperitoneally with 100/~g of DNP-KLH and then bled 7 days there- 
after. 
As depicted graphically in Fig. 3, the lowest dose  (1/zg) of DNP-D-GL sup- 
pressed the secondary anti-DNP response by only 50 %  as compared with con- 
trols. While considerably more suppression  (90%)  was obtained with  10 >g of 
DNP-D-GL, doses of 50/~g or greater were required for complete abolition of the 
anti-DNP response. This dose-response relationship is consistent with our recent 
observations in guinea pigs in which we have shown preferential  depletion  of 
high  affinity  antibody-forming  cells  after  treatment  with  DNP-D-GL  (14). 
Finally, it should also be noted that in these latter three experiments the DNP- 
KLH-primed cells were injected intraperitoneally indicating that either route of 
adoptive cell transfer may be used. 
Induction  of DNP-Specific  Tolerance by  Incubation  of DNP-KLH-Primed 
Cells In  Vitro with DNP-D-GL  before Adoptive  Transfer.--Having  established 
conditions for induction of tolerance in DNP-primed cells in an adoptive trans- 
fer system by treating recipients in vivo with DNP-D-GL, it was of interest  to 
determine whether or not the same result could be obtained by incubating such 
cells in vitro with DNP-D-GL before transfer. 
Two types of experiments were performed along these lines. In the first experiment, spleen 
cells from A/J mice primed 2 months earlier with 100/zg of DNP-KLH in CFA were cultured 
in slightly modified MishelI-Dutton conditions (23). At a cell density of 30 X  106 cells/ml, 
these primed cells were incubated with either DNP-D-GL (3/zg/10 ~  cells) or saline. At intervals 
of 24, 48, and 72 hr, ceils were harvested from the dishes, washed three times with MEM, and 
counted. Equal numbers of viable (trypan blue exclusion), saline-control cells and cells incu- 
bated with DNP-D-GL were transferred  intraperitoneally  to respective groups of irradiated 
(450 R),  syngeneic A/J  recipient  mice. Secondary challenge with  100  #g of DNP-KLH 
intraperitoneally was performed immediately after cell transfer and the mice were bled 7 d~s 
later. 
As shown in Fig. 4, incubation with DNP-D-GL resulted in suppression of the 
secondary  adoptive  transfer  responses  to DNP-KLH  which varied  in  degree 
with the length of in vitro incubation. Thus, cells incubated for 24 hr with the 
tolerogen  developed  adoptive  secondary responses  which  were  suppressed  by DAVID H.  KATZ, TOSHIYUKI  HAMAOKA, BARUJ BENACERRAF  1411 
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FIG. 3.  Dose-response relationship of DNP-D-GL to induction of DNP-specific tolerance 
in the adoptive cell transfer system in A strain mice. Spleen cells from A/J donor mice, primed 
30 days earlier with 100 #g of DNP-KLH in CFA, were injected intraperitoneally (50 X  106 
cells/recipient) into irradiated  (450 R), syngeneic recipients. Immediately after cell transfer, 
groups of recipients (6 mice/group) were treated with varying doses  (1, 10, 50, 200, or 500 #g) 
of aqueous DNP-~-GL intraperitoneally,  or were not  treated.  3  days  later,  all mice were 
secondarily challenged with  100 #g of DNP-KLH in saline i.p.  Serum anti-DNP antibody 
levels on day 7 after secondary challenge are illustrated. 
75 %  as compared with those obtained  with control cells incubated  with saline. 
Prolongation of the culture period to 48 or 72 hr resulted in levels of suppression 
of 97  and  91%,  respectively, in  cells incubated  with DNP-D-GL  as compared 
with controls. 
A second type of experiment was carried out in which DNP-KLH-primed A/J donor spleen 
cells (30 days after priming) were incubated in stationary tubes with or without DNP-D-GL 
(3 #g/10 g cells) for short periods of time in a standard 5% CO~-air atmosphere. After 1 or 4 hr, 
ceils incubated in vitro with saline or DNP-D-GL were washed three times and then injected 
intraperitoneally (66  X  106 cells/recipient) into irradiated,  syngeneic recipients. Additional 
control mice received DNP-KLH-primed cells from the same pool which had not been incu- 
bated at all in vitro. Certain groups of recipients were challenged with 100/zg of DNP-KLH 
intraperitoneally immediately after cell transfer whereas other groups did not receive secondary 1412  TOLERANCE  IN B  LYMPHOCYTES 
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Fzo. 4.  Induction of DNP-specific tolerance in vitro by incubation of DNP-KLH-primed 
ceils with DNPm-GL in Mishell-Dutton cultures before adoptive transfer. Spleen cells from 
A/J mice, primed 2 months earlier with 100 #g of DNP-KLH in CFA, were cultured in slightly 
modified Mishell-Dutton conditions (cell density 30 X  106/ml) with either saline or DNP-D-GL 
(3 #g/106 calls). At intervals of 24, 48, and 72 hr, cells were harvested from the dishes and 
washed three times with MEM. Equal numbers of viable saline control cells and ceils incubated 
with DNP-D-GL were  transferred intraperitoneally to respective groups  (5 mice/group)  of 
irradiated (450 R), syngeneic recipient mice. The numbers of viable cells of each type trans- 
ferred to individual recipients were 42 X  106 at 24 hr, 38.5  X  106 at 48 hr, and 20 )< 106 at 
72 hr. All mice were secondarily challenged with 100/zg of DNP-KLH in saline i.p, immedi- 
ately after cell transfer. Serum anti-DNP antibody levels on day 7 after secondary challenge 
are illustrated. Statistical comparisons of the responses of recipients of saline control cells and 
calls exposed to DNP-D-GL yielded P  values of 0.005  >  P  >  0.001 in all cases. 
challenge until 3 days after cell transfer. All mice were bled 7 days after secondary challenge. 
The results of this experiment are illustrated graphically in Fig. 5. 
Incubation with DNP-D-GL for either 1 or 4 hr resulted in significant reduc- 
tions of the adoptive secondary anti-DNP responses in all cases as compared 
with controls. However, there was a not inconsiderable difference in the degree 
of tolerance observed in groups receiving cells incubated for only 1 hr which was 
related to the time of secondary challenge. Thus, when DNP-KLH challenge 
was performed immediately after cell transfer, cells preincubated with DNP-D- 
GL were suppressed by 73 % as compared with control cells incubated with sa- DAVID H.  KATZ,  TOSHIYUKI  tlAMAOKA,  BARU] BENACERRAF  1413 
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FIG. 5.  Induction of DNP-specific tolerance in vitro by incubation of DNP-KLH-primed 
cells with DNP-D-GL in stationary cultures before adoptive transfer.  Spleen cells from A/J 
mice, primed 30 days earlier with 100 #g of DNP-KLH in CFA, were incubated in stationary 
tubes with or without ]DNP-1)-GL (3 #g/106 cells) for 1 or 4 hr in a 5% CO2-air environment. 
At the end of the incubation, cells were washed three times and then injected intraperitoneally 
(66 X  106 cells/recipient) into irradiated (450 R), syngeneic recipients. Additional control mice 
received DNP-KLH-primed cells which had not been incubated at all in vitro. Certain groups 
of recipients were challenged with 100/.~g of DNP-KLH in saline intraperitoneally immediately 
after cell transfer (left panel) whereas other groups did not receive secondary challenge until 
3 days after cell transfer  (right panel). Mean serum anti-DNP antibody levels of groups of 
5 mice on day 7 after secondary challenge are illustrated.  Statistical comparisons of the re- 
sponses of recipients of saline control cells and cells exposed  to DNP-D-GL  yielded  the  fol- 
lowing results.  (a)  Left panel:  1 hr, 0.05  >  P  >  0.025; 4  hr, 0.01  >  P  >  0.005.  (b)  Right 
panel: 1 hr, 0.005  >  P  >  0.001; 4 hr, 0.005  >  P  >  0.001. 
line; when secondary challenge was delayed until 3  days after cell transfer,  the 
level of suppression  was  91%.  This difference,  as well as the fact that,  in gen- 
eral, the degree of DNP-specific tolerance obtained by in vitro incubation with 
DNP-D-GL was less than that obtained by in vivo administration  of tolerogen, 1414  TOLERANCE  IN  B  LYMPHOCYTES 
may reflect the operation of as yet unknown in vivo mechanisms which may 
serve to facilitate the intracellular tolerizing events. 
Maintenance of DNP-Specific Tolerance after Serial Adoptive Cell Transfers.- 
Recently, independent investigators have reported that removal and transfer of 
lymphocytes from tolerant animals to nontolerant,  syngeneic, irradiated  recip- 
ients results in rapid loss of the  tolerant  state  (20-22). These and related ob- 
servations concerning "self-recognition" phenomena in vitro have raised serious 
questions  about the nature and mechanisms of central immunologic tolerance. 
When dealing with tolerance models involving both T  and B  lymphocytes, the 
matter of interpretative  construction of results must of necessity be extremely 
complex.  However,  when  the  tolerant  state  being  studied  is  shown  to be  an 
isolated  B  cell-specific  tolerance,  the  issue  becomes rather  clear-cut:  in  such 
instances,  tolerance either reflects a central  (i.e., intracellular)  inhibitory state 
or a  surface  (i.e.,  receptor-blocking)  event.  If  the  former is  true,  one  would 
expect  tolerance  not to be easily reversible  and not to depend  (once fully in- 
duced) on the constant presence of tolerogen; the converse reasoning applies to 
the latter  alternative.  In the first  experiments  described  above  (Table  I), we 
observed that DNP-K_LH-primed cells obtained  from donors which had been 
treated with DNP-D-GL 7 days before adoptive transfer appeared to maintain a 
significant degree of tolerance in the untreated irradiated recipients. This result 
suggests a true central tolerizing event in this model. We performed the follow- 
ing series of experiments to approach this question more completely. 
50 x  10 a spleen cells from A/J mice primed with DNP-KLH 46 days earlier were injected 
intravenously  into two groups of syngeneic, irradiated  (500 R)  recipients. Two additional 
groups of recipients were injected with cells from identically primed donors which had been 
treated with 1.0 mg of DNP-D-GL intraperitoneally 7 days before transfer. Immediately after 
cell transfer, recipients were treated with either DNP-D-GL or saline and then challenged 3 days 
later with DNP-KLH. 7 days after  secondary challenge, mice in each group were bled and 
killed. Suspensions of their spleen cells were prepared and adoptively transferred  (50 N  108 
cells/recipient) to groups of new irradiated,  syngeneic recipients who were then divided into 
subgroups  which  were  either  subjected  to  DNP-D-GL  treatment  (immediately  after  cell 
transfer) or not. 3 days after cell transfer, these new recipients were challenged with DNP-KLH 
and then bled 7 days later. 
The  protocol  and  results  of this  experiment  are  summarized  in  Fig.  6.  As 
shown in the earlier experiments,  the secondary anti-DNP response in the first 
adoptive transfer was abolished by DNP-D-GL treatment of either the recipient 
immediately  after  cell  transfer  (groups II and  IV)  or of the DNP-KLH  cell 
donors 7 days before transfer  (group III). When these first transfer recipients 
were then used as donors for the second adoptive ceil transfer,  the results very 
clearly show  that  such manipulation  does not  result  in a  loss of the  tolerant 
state.  Thus,  group  1 recipients  of cells  which had  never been  exposed  to the 
tolerogen  developed  very  good  anti-DNP  antibody  responses.  In  contrast, 
recipients of cells which had been exposed to DNP-D-GL in the first transfer, ~  0~.  ~  0  . 
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but not  subsequently  (group  3),  manifested profound  DNP-specific  tolerance. 
Even  more  striking,  however,  is  the  fact  that  a  highly  significant  degree  of 
tolerance was evident in group 5 recipients whose cells had not been exposed to 
DNP-D-GL since the original donors were so treated 24 days earlier. It follows, 
therefore, that recipients in group 7 should be tolerant,  as indeed they were. As 
expected,  essentially  no  secondary  response  was  obtained  in  recipient  mice 
treated with DNP-D-GL after the second transfer (groups 2, 4, 6, and 8). 
Elimination of the Possiblity of Carry-Over of Tolerogen As the Explanation for 
Maintenance  of  the  Tolerant  State  in  Serial  Adoptive  Cell  Transfers.--These 
results immediately raised questions in our minds as to the possibility that we 
were  not  only  serially  transferring  cells  but  small  tolerogenic  doses  of 
DNP-I)-GL as well.  We  approached  this problem by repeating  and  modifying 
the preceding experiment in part. 
Thus, groups 1 and 2 of the first adoptive transfer were set up as shown in Fig. 6. On day 7 
after DNP-KLH challenge, the animals were bled (yielding results comparable  to those shown 
in Fig. 6) and their spleen cells adoptively transferred intravenously to new recipients (50 X 10 ~ 
cells/recipient).  Certain groups of recipients of cells rendered  tolerant by DNP-D-GL in the 
first adoptive transfer were also injected,  on the same day, with varying numbers of spleen 
ceils from DNP-KLH-primed donor mice. Comparable groups of mice which received only the 
respective numbers  of these  "fresh" DNP-primed cells were established  as controls.  3 days 
later all mice were secondarily  challenged with 100 #g of DNP-KLH and then bled  7 days 
thereafter. 
The data from the second transfer of this experiment are depicted graphically 
in  Fig.  7.  The  left panel  of this  figure reiterates  the  observation made  in the 
preceding  experiment,  namely  that  the  DNP-specific  tolerant  state  is  main- 
tained in ceils transferred to a second recipient (solid bar). However, when these 
tolerant cells are transferred simultaneously with freshly obtained DNP-KLH- 
primed cells they do  not  exert a  suppressive  effect on the  adoptive  secondary 
anti-DNP  response (open bars of right panel, Fig. 7). This was true even when 
relatively low numbers (12.5  X  106) of fresh DNP-primed cells were employed. 
It is not immediately clear why the combination of tolerant cells and fresh DNP 
cells gave somewhat better responses than fresh cells alone, although the differ- 
ences  are  not  statistically  significant.  This  experiment,  therefore,  argues 
strongly against the possibility that DNP-D-GL has been serially transferred in 
quantities  sufficient  to  maintain  the  tolerant  state  in  these  cells,  and  points 
emphatically to the  existence  of a  central,  intracellular  mechanism  of specific 
paralysis. 
Evidence  That  Tolerance Induced  by DNP-D-GL  is Not Merely  Re~ective of 
Blocking  of Surface Receptors.--In  the  previous  experiments,  we were  able  to 
induce DNP-specific tolerance in a classical adoptive cell transfer system either 
by (a) preincnbating  DNP-KLH-primed  cells in vitro with DNP-D-GL,  or (b) 
administering  DNP-D-GL  either  to  the  DNP-KLH-primed  cell  donor  mice  7 
days  before  cell  transfer  or  to  the  recipients  of  such  cells  immediately  after DAVID  H.  KATZ, TOSHIYUKI HAMAOKA,  BARUJ  BENACERRAF  1417 
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FI6.  7.  Elimination  of the  possibility of carry-over of tolerogen in serial adoptive  cell 
transfers. The experimental groups I and II of Fig. 6 were established using spleen cells from 
A/J donor mice primed 51 days earlier with 100 #g of DNP-KLH in CFA. The results ob- 
tained in these two adoptive transfer groups were comparable with those shown in Fig. 6. 
Spleen cells from these first transfer recipients were then adoptively transferred intravenously 
to new recipients (50  X  106 cells/recipient). Certain groups of recipients of cells rendered 
tolerant by DNP-D-GL in the first adoptive transfer were also injected, on the same day, with 
varying numbers of spleen cells from DNP-KLH-primed donor mice. Comparable groups of 
mice which received only  the  respective numbers  of  these fresh  DNP-primed  cells were 
established as controls. 3 days later all mice were secondarily challenged with  100 #g of 
DNP-KLH and then bled 7 days thereafter. Mean serum anti-DNP antibody levels of groups 
of 5 mice on day 7 after secondary challenge are shown. 
transfer but before secondary challenge with DNP-KLH. One of the  critical 
questions raised by such results is whether the suppression of antibody forma- 
tion reflects  blocking of receptor molecules present on  the  surface of DNP- 
specific  B  lymphocytes.  Although  the  preceding  experiments demonstrating 
maintenance of  the  tolerant  state  through  serial  adoptive  transfers  argues 
against a predominantly  surface mechanism, they fail to provide direct evidence 
on this point. The following experiments were designed and carried out to ex- 
plore this question more fully. 1418  TOLERANCE  IN  B  LYMPHOCYTES 
Relationship  of time of administration  of DNP-D-GL  to  adoptive  cell transfer 
recipients to the induction of DNP-specific tolerance and failure to induce tolerance 
in vivo with immunogenic DNP-carrier conjugates:  We reasoned that one appro- 
priate  way  to  examine  this  was  to  make  a  comparative  study  in  which  the 
toierogenic  substance,  DNP-D-GL,  or  immunogenic  DNP-carrier  conjugates, 
DNP-OVA  or DNP-BGG,  were administered to the adoptive transfer recipients 
either before or after cell transfer and secondary challenge. 
Spleen cells from A/J donor mice, which had been primed with DNP-KLH 30 days earlier, 
were injected intraperitoneally (36  ;<  10 ~ cells/recipient) into syngeneic,  irradiated  (450  R) 
recipients. Secondary challenge with 100/zg of DNP-KLH  intraperitoneally was  performed 
immediately after cell transfer. Four groups of recipient mice had been treated  3 days before 
irradiation, cell transfer, and secondary challenge with intraperitoneal injections  of 500  /~g 
of either DNP-OVA, DNP-BGG, or DNP-D-GL in saline, or saline alone, while another four 
groups of recipient mice received identical treatments 2 days  after  irradiation, cell  transfer, 
and challenge. All mice were then bled 7 days after secondary challenge. 
The results are summarized in Table II. Recipients treated with saline alone, 
TABLE  II 
Relatlons/zip of Time of Administration  of DNP-D-GL  to the Induction  of DNP-Specific 
Tolerance in  Adoptlvely  Transferred DNP-KLH-Prlmed Spleen, Cells, and Failure 
to Induce  Tolerance with Immunogenic DNP Conjugates 
Group 
Protocol* 
Time of treatment of recipients  Treatment 
Anti-DNP antibody~; 
Day 7 after secondary 
challenge 
A 
B 
C 
D 
3 days before cell transfer and 
secondary challenge 
E  2 days after cell transfer and 
F  secondary challenge 
G 
H 
p.g / raI 
None  370.7  (1.24) 
500  /~g DNP-OVA  319.8  (1.38) 
500  ~zg DNP-BGG  218.3  (1.42) 
500  #g  DNP-I)-GL  52.3  (1.14) 
None  297.0  (1.14) 
500  #g  DNP-OVA  312.7  (1.25) 
500 ~g  DNP-BGG  278.9  (1.31) 
500  /.~g DNP-D-GL  11.1  (1.10) 
* 36 X  10  ~ spleen cells from A/J donor mice which had been primed 30 days  earlier with 
100/~g of DNP-KLH in CFA were injected intravenously into individual irradiated (450 R), 
syngeneic recipients. Secondary challenge with 100/zg of aqueous DNP-KLH intraperitoneally 
was  performed immediately after cell transfer.  Recipient  mice were  treated with  500  /zg 
of  aqueous  DNP-OVA,  DNP-BGG,  or  DNP-D-GL  intraperitoneally  either  3  days  before 
cell transfer and secondary challenge (groups B, C, and D)  or 2 days after cell transfer and 
secondary challenge. 
$ The data are expressed as geometric means of serum anti-DNP antibody levels of groups 
of S mice 7 days after secondary challenge. Numbers in parentheses represent standard errors. 
A  comparison  of  geometric  mean  antibody levels  gave the  following results. Comparison 
of group A with groups B and C yielded P  values of 0.80 >  P  >  0.70 and 0.30 >P  >  0.20, 
respectively. Comparison of groups A, B, and C with group D yielded P  values of 0.001  >  P 
in all cases. Comparison of groups E, F, and G with group H  yielded P  values of 0.001  > 
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DNP-OVA, or DNP-B GG displayed comparable secondary anti-DNP antibody 
responses irrespective of whether such treatment was administered 3 days before 
(groups A, B,  and  C)  or 2  days after  (groups E,  F,  and  G)  cell  transfer  and 
challenge. On the other hand,  and in marked contrast,  recipients  treated  with 
DNP-D-GL at either time relative to transfer and challenge (groups D  and H) 
manifested  profoundly  suppressed  secondary  anti-DNP  antibody  responses. 
These  results  provide  two  reasonable  arguments  against  a  receptor-blocking 
concept as the explanation for the DNP-specific tolerance being studied.  First, 
if receptor  blocking alone  were  responsible,  it  is  difficult  to  understand  why 
DNP-OVA  or DNP-BGG,  which  are  most probably  bound  by receptors  on 
DNP-specific B cells (but, in this circumstance, fail to trigger such cells), failed 
to competitively inhibit  the  response  to DNP-KLH.  Second,  and  even  more 
important, is the fact that DNP-D-GL exerted a tolerogenic effect even when it 
was administered  2 days after secondary challenge with DNP-KLH  (group H) 
at a  time when, presumably,  a competitive receptor inhibition  could no longer 
operate effectively. 
Failure to reverse tolerance induced in vitro with DNP-D-GL by trypsinization of 
cells before adoptive transfer to irradiated recipients:  The second approach to the 
question of receptor blocking took advantage of the capacity, shown earlier,  to 
induce a  significant level of tolerance by incubating primed cells in vitro with 
DNP-D-GL. 
Spleen cells were obtained  from A/J  donor mice which had  been primed  with  100  #g 
of DNP-KLH in CFA 30 days earlier and boosted with same 15 days  before sacrifice. These 
primed cells were incubated in Mishell-Dutton conditions at a  density of 30 X  106 cells/ml 
with 3/~g/106 cells of either DNP-D-GL, DNP-OVA, DNP-KLH, or saline alone. After 48 hr, 
the respective cell groups were harvested from the dishes and washed three  times with  MEM. 
Each pool was divided into two samples. One sample was  left untreated  while the  second 
sample was treated with trypsin as follows: 30 X  106 cells were incubated for 20 rain at 37"C 
in 1.0 ml of a freshly prepared solution containing 150/zg/ml trypsin and 10/~g/ml  DNAase 
(Worthington Biochemical Corp., Freehold, N.J.)  in MEM. After  trypsinization,  the  cells 
were washed three times. Groups of irradiated  (500 R), syngeneic recipient mice were injected 
intravenously with either untreated  or trypsinized cells from the respective culture groups. All 
mice were secondarily challenged with  100/zg of DNP-KLH intraperitoneally in  saline im- 
mediately after cell transfer and then bled 7 days later. 
The results are summarized in Table III. It should be noted from the outset 
that  a  considerable  disparity  exists  between  the  numbers  of untreated  and 
trypsin-treated  cells  transferred  to  each  recipient.  This  resulted  from a  con- 
siderably higher cell loss than was expected from trypsinization.  Recipients of 
saline-incubated cells (groups A and B) displayed very good adoptive secondary 
anti-DNP  responses  whether  or  not  the  transferred  cells  were  trypsinized. 
Recipients  of cells  exposed  to  DNP-D-GL  in  vitro  (groups  C  and  D)  were 
markedly suppressed  in their secondary responses  (95 %  or more as compared 
with  controls).  Most importantly,  treatment  with  trypsin did not abolish  the 
unresponsive state.  In striking contrast are the results obtained in recipients of 
cells incubated with DNP-OVA. If such cells were transferred without trypsini- 1420  TOLERANCE IN  B  LYMPHOCYTES 
"FABLE III 
Failure  to  Reverse Tolerance  Induced  in  Vitro  with  DNP-v-GL  by  Trypsinization  of  Cells 
before Adoptive  Transfer  to Irradiated  Recipients 
Protocol* 
Ceils incubated  in vitro  No trypsin  Trypsin-treated 
with: 
No. of cells  Group  No. of cells  Anti-nNP;  Group  Anti-DNPI:  transferred  transferred 
Saline  A  20  X  106  2471.3  B  10  X  106  1621.0 
DNP-D-GL  C  20  X  10  o  107.4  D  13  X  106  55.8 
DNP-OVA  E  20  N  106  172.4  F  10  N  106  1212.1 
DNP-KLH  G  20  X  106  1384.7  H  7  X  106  447.3 
* Spleen cells from A/J  mice, primed  and boosted 30  and  15  days,  respectively, with 
100 gg of DNP-KLH in CFA, were incubated for 48 hr in vitro, with saline, DNP-D-GL, 
DNP-OVA, or DNP-KLH (the latter three at a dose of 3 gg/106 ceils). At the end of the 
culture period, cells were thoroughly washed and then divided into two samples. One sample 
of each type  was then incubated  (20 rain,  37°C) with  trypsin (5  /~g/106 cells) and then 
washed. The second sample of cells was left untreated.  Groups of irradiated  (500 R), syn- 
geneic recipients were injected intravenously with untreated or trypsinized cells of the type 
and in numbers as indicated above. Immediately after cell transfer all mice were challenged 
with 100 #g of DNP-KLH intraperitoneally in saline. 
:~ The data are expressed as geometric means of serum anti-DNP antibody levels of groups 
of 5 mice 7 days after secondary challenge. A comparison of geometric mean antibody levels 
gave the following results.  Comparison of group A or group B with groups C,  D, and E 
yielded P values of 0.001 >  P in all cases. Comparison of group F with group E also yielded 
a P  value of 0.001 >  P. Comparison of group A with group G yielded a P  value of 0.30 > 
P  >  0.20. 
zation (group E), a very significant level of suppression (93 %) occurred. Treat- 
ment of such cells with trypsin, on the other hand, restored the adoptive second- 
ary anti-DNP response to  essentially normal levels (group F).  Incubation of 
cells with the homologous antigen (DNP-KLH) did not significantly alter the 
adoptive secondary response (group G). It is not immediately clear to us why 
the response of group H  recipients of trypsinized cells was somewhat lower. 
Since  trypsin presumably removes  surface  receptors  (and  any  associated 
antigen), these results indicate that  (a)  the  suppression observed in group E 
reflected  blocking of  surface  receptor  molecules by DNP-OVA;  and  (b)  the 
failure of trypsinizafion to reverse unresponsiveness  of DNP-D-GL-exposed cells 
must, by converse reasoning, reflect more complex inhibitory events not pre- 
dominantly  related to reversible surface membrane factors. 
DISCUSSION 
In the studies reported here, we have shown that administration of the DNP 
derivative of  the  copolymer of  D-glutamic acid  and D-lysine to  inbred mice 
induces a  state of DNP-specific tolerance in such animals irrespective of their 
immune status at the time of treatment. These results confirm and extend to DAVID  H.  KATZ,  TOSHIYUKI  HAMAOKA, BARUJ  BENACERRAF  1421 
mice our previous observations on DNP-specific tolerance in inbred guinea pigs 
(4).  In  the latter studies, we presented evidence for a  central mechanism of 
tolerance which is expressed predominantly in the population of DNP-specific 
antibody-forming cell precursors. This interpretation is derived from the finding 
that  the  tolerance is hapten-specific and  that  the  frequency of both  DNP- 
specific,  antigen-binding lymphoid cells and anti-DNP, antibody-forming cells 
is significantly lower in guinea pigs tolerized with DNP-D-GL than in normal or 
immune animals (4, 14). Moreover, subsequent studies in the guinea pig model 
have demonstrated that a very marked depression, both in plaque-forming cells 
secreting high affinity anti-DNP antibody and in high affinity serum anti-DNP 
antibody, exists in this model, indicating a preferential tolerization of precursor 
cells bearing high affinity receptors (14). 
A rather unique feature of the DNP-D-GL tolerance model is the relative ease 
with which tolerance can be induced in an animal previously immunized with an 
immunogenic DNP-carrier conjugate (4). In the present studies, we have taken 
advantage of this feature to establish conditions for tolerance induction in an 
adoptive transfer system in mice. (These studies have been performed under the 
conscious assumption that basic mechanisms of cell  inactivation are  funda- 
mentally the same in primed and unprimed immunocompetent cell populations.) 
Thus, spleen cells from DNP-KLH-primed donor mice normally developed very 
good  adoptive secondary anti-DNP  antibody responses  to DNP-KLH upon 
transfer to syngeneic, irradiated recipients. However, exposure of such DNP- 
primed  cells  to  the DNP-D-GL  tolerogen completely, or  almost completely, 
abolished  the  adoptive  secondary  response.  This  was  true  irrespective  of 
whether the DNP-primed cells were exposed to DNP-D-GL in the donor animal 
before adoptive transfer or in recipient mice after transfer. In the latter situa- 
tion, it was possible to show a very clear dose-response relationship for tolerance 
induction with DNP-D-GL which is consistent with the above-mentioned ob- 
servations on preferential depletion of high affinity antibody-forming cells  in 
guinea pigs (14). 
Incubation of DNP-KLH-primed cells with DNP-D-GL in vitro under vary- 
ing culture  conditions also  resulted in depression  of the  adoptive secondary 
response of such cells although the kinetics and degree of tolerance induction in 
this way were slightly different from that obtained by in vivo tolerization. Thus, 
treatment of adoptive transfer recipients in vivo resulted in virtually complete 
tolerance induction within 1 hr after administration of an appropriate dose of 
DNP-D-GL.  In contrast, when DNP-KLH-primed cells  were incubated with 
DNP-D-GL in vitro for 1 hr, washed, and then transferred to irradiated recip- 
ients,  the  adoptive  secondary response  to  DNP-KLH  challenge  performed 
immediately after  cell  transfer  was  depressed  by  73%  but  not  completely 
abolished. Allowing such cells to reside in the recipient for 3 days before second- 
ary challenge resulted in a  higher level  of tolerance  (91%  suppression).  The 
kinetics of tolerance induction in vitro also varied somewhat with the culture 1422  TOLERANCE  IN  B  LYMPHOCYTES 
conditions employed. Incubation in stationary tubes for 4 br resulted in greater 
than 90% suppression as compared with 75 % suppression obtained after 24 hr 
incubation  in  Mishell-Dutton  conditions,  Nonetheless,  essentially  complete 
tolerance occurred after incubation for 48 hr or longer in the latter conditions. 
These kinetic differences, as well  as  the  fact that,  in  general,  the  degree of 
DNP-specific tolerance obtained by in vitro incubation with DNP-D-GL was 
less than that obtained by in vivo administration of tolerogen, may reflect the 
operation of as yet unknown in vivo mechanisms which may serve to facilitate 
the intracellular tolerizing events. 
In view of the very detailed studies by Chiller et al. (1) on kinetics of tolerance 
induction to deaggregated human gamma globulin (HGG), which demonstrate a 
rather long latent period for initiation  (8 days)  and completion (21  days) of 
tolerance in bone marrow cells (although recent studies indicate that peripheral 
B lymphocytes in spleen become tolerant within 3 days; J. M. Chiller, personal 
communication),  it  is  essential  to  explain  the  extremely  rapid  kinetics  of 
tolerization observed with DNP-D-GL. This is perhaps best explained by the 
critical difference, which may likely exist, in the cell types involved in the two 
systems. Thus, tolerance induction to HGG or other thymus-dependent anti- 
gens  very clearly involves the  establishment  of tolerance in  both  T  and  B 
lymphocytes, the former being rendered tolerant much more rapidly and with 
lower concentrations of tolerogen (1, 2). It is conceivable that in such situations 
tolerance induction in B lymphocytes follows a rather inefficient course until a 
state of absolute tolerance in all T lymphocytes of corresponding specificity has 
been established. In the case of DNP-D-GL, on the other hand, tolerance induc- 
tion  may involve exclusively the  specific B  lymphocyte population.  As  the 
copol)aner of I~-GL is either nonimmunogenic or only marginally immunogenic 
in guinea pigs (4) and mice (unpublished observations), it seems likely that T 
lymphocytes specific for this substance do not exist or are nonfunctional. Based 
on this assumption,  we have previously hypothesized that  the tolerant state 
resulting from DNP-D-GL treatment reflects direct interaction of DNP-specific 
B lymphocytes with the substance, in appropriate concentrations, in the absence 
of a concomitant T  cell influence (4, 13). This hypothesis is strengthened by our 
observation that  a nonspecific T  cell  activation caused by a  graft-versus-host 
reaction (allogeneic effect) (24) results in the development of immunity rather 
than tolerance to DNP-D-GL in both guinea pigs  (4)  and mice  (25).  In  this 
context, it  appears  that  tolerance induction  in  B  lymphocytes does proceed 
along a more rapid kinetic course than in a thymus-dependent system such as 
that of Chiller and Weigle (1, 2). Indeed, this reasoning is supported by previous 
studies on tolerance induction in vitro to thymus-independent antigens such as 
polymerized flagellin (POL)  (26)  or Escherichia coli  lipopolysaccharide (LPS) 
(27) where the kinetics of induction have been rapid, as in our experiments here, 
resembling those observed with thymus cells in vivo. It is probably also relevant 
to note that attempts to induce specific tolerance in vitro with thymus-depend- 
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A  critical question in  any model  of tolerance concerns the  mechanism  by 
which suppression of antibody formation occurs. Specifically, what happens to a 
tolerant cell?  Does it  exist in  a  functionally unresponsive or unrecognizable 
state, or is it eliminated from the system? The available evidence from studies 
on antigen-binding cells may appear conflicting in that some investigators have 
found normal numbers of such cells (5-8) while others have found diminished 
numbers  (3,  4)  in  tolerant  animals.  These  apparent  contradictions may be 
readily resolved, it seems to us, by the following considerations. 
(a) In the case of tolerance in thymus-dependent antigen systems, the pres- 
ence and frequency of antigen-binding cells  (representing B  cell precursors of 
antibody-forming cells) will depend on the nature of the target cell involved and 
the degree of tolerance existing at the time cells are examined. Hence, where 
tolerance exists predominantly among T  cells,  one would expect to find rela- 
tively normal numbers of antigen-binding cells. However, where B cell tolerance 
is achieved, even for a  thymus-dependent antigen, such as HGG, Chiller has 
recently observed that specific antigen-binding cells are significantly diminished 
in tolerant animals (J. M. Chiller, personal communication). 
(b) In both thymus-dependent and thymus-independent systems, the detec- 
tion of antigen-binding cells in a tolerant animal in which some degree of B cell 
tolerance  exists  may  depend  upon  the  receptor  affinity  of  the  cells  being 
studied. In view of the fact that tolerance results in preferential diminution of 
high affinity antibody-forming cells and antibodies (14, 29-31), antigen-binding 
cells  detected  in  such  circumstances  may be  predominantly of low  affinity 
receptor type, whereas high affinity cells may be significantly diminished. 
(c) Finally, one must bear in mind the nature of the tolerant state induced. 
This point appears to be particularly applicable to the tolerance induced to the 
polysaccharide of Type III pneumococcus (Sin) and to E. coli lipopolysaccha- 
ride (LPS), both of which are thymus-independent antigens (32-36). As recently 
reviewed by Howard (20, Sin) and by MiSller and SjiSberg (22, LPS), some out- 
standing  common features shared by these  tolerance models include  (a)  the 
presence of increased numbers of specific antigen-binding cells in tolerant ani- 
mals which, nevertheless, possess markedly diminished numbers of antibody- 
forming cells; (b) the rapid loss of tolerance upon transfer of cells from tolerant 
donors to irradiated, syngeneic recipients; and (c) the relative incapacity of such 
substances to be catabolized. Howard (20) has concluded that the tolerant state 
to Sm is therefore reflective of a complexity of events involving three different 
mechanisms that include continuous peripheral neutralization of secreted anti- 
body,  and  predominantly reversible and  some irreversible inactivation  of B 
lymphocytes. These complex events do not appear to play the predominant role 
in  the  tolerance achieved with DNP-D-GL which  is most likely reflective of 
intracellular inactivation. 
In  the  context  of  the  above  considerations,  we  have  utilized  several 
approaches  in  the  present  studies  to  probe  the  questions  of mechanism  of 
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immediate  question  concerned  the  possibility  that  suppression  of  antibody 
formation reflects blocking of surface receptor molecules on DNP-specific B 
lymphocytes. This possibility has been ruled out by the following observations: 
(a) The failure to induce tolerance in the adoptive transfer system by treatment 
of recipients of DNP-KLH-primed cells with immunogenic conjugates of DNP- 
OVA or DNP-B GG under circumstances where profound tolerance was induced 
by DNP-mGL. If receptor blocking alone is responsible for this DNP-specific 
tolerance, one might expect that DNP-OVA  or DNP-BGG, which  are most 
probably bound by receptors on DNP-specific B cells (but, in this circumstance, 
fail  to  trigger  such  cells),  would  competitively  inhibit  the  response  to 
DNP-KLH. 
(b) More importantly, the capacity to induce tolerance with DNP-D-GL even 
when it was  administered  2 days  after adoptive cell transfer and secondary 
challenge. In this case, exposure of the cells to DNP-D-GL occurred at a time 
when,  presumably,  a  competitive receptor inhibition could no longer operate 
effectively. 
The  most  conclusive  evidence  that  DNP-D-GL  tolerance  involves  more 
sophisticated events than receptor blockade derives from the failure of enzy- 
matic treatment by trypsin of cells tolerized by DNP-D-GL in vitro to reverse, 
or even diminish,  the  level of unresponsiveness manifested by such  cells.  If 
these cells still had been capable of responding to DNP-KLH but could not do 
so because all of their surface receptors were competitively blocked by DNP- 
D-GL, then this situation should have been corrected by trypsinization. Indeed, 
the  results obtained in the very same experiment by incubation with DNP- 
OVA offer perhaps the best example of the sharply contrasting mechanisms that 
may contribute to unresponsiveness. Thus, since suppression of the adoptive 
secondary response after DNP-OVA incubation was readily, and completely, 
reversed by trypsinization, it is clear that unresponsiveness in this case resulted 
from effective (and  reversible) receptor blockade. This illustrates,  moreover, 
that such a  mechanism can significantly inhibit antibody production, though 
the prediction seems valid that unresponsiveness of this type is probably very 
transient in nature. Failure of trypsinization to reverse the unresponsiveness 
induced by DNP-D-GL, on the other hand, supports the conclusion that such 
cells have been inactivated via intracellular mechanisms.  A  tolerant state of 
this type would be predictably long lasting. 
The other observations reported here that bear on the issues cited above are 
those dealing with the serial transfer of tolerance. Thus, cells rendered tolerant 
by DNP-D-GL manifested  the  unresponsive  state  through  as  many  as  two 
serial  adoptive  transfers  to  irradiated,  syngeneic  recipients.  This  was  true, 
furthermore, over a period of time of at least 24 days from the initial, and only, 
exposure of such  cells to  the  tolerogen. The possibility that maintenance  of 
tolerance through such serial transfers was due to transfer of tolerogenic doses 
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neous  adoptive  transfer of large  numbers  of tolerant  cells with  nontolerant 
DNP-KLH-primed cells did not diminish the secondary response of the latter 
to DNP-KLH. 
If, as we propose, the tolerance induced by DNP-D-GL is a restricted B cell 
tolerance, then these results on serial transfer of the tolerant state are informa- 
tive with respect to understanding the mechanism of tolerance in B  lympho- 
cytes. The results obtained with  thymus-independent antigens  depends very 
much upon the system used. Thus, as mentioned above, tolerance induced in 
vivo to certain thymus-independent antigens, S,~I and LPS, is characteristically 
(and rapidly) lost after adoptive transfer (20-22). Tolerance to other thymus- 
independent antigens is both long lasting and transferable as in the case of the 
fructose polymer, levan  (J.  Miranda,  cited  by Howard  [20]).  This  thymus- 
independent antigen induces a state of B  cell tolerance which is not lost upon 
adoptive transfer.  Similarly, in the system of tolerance induction in vitro to 
thymus-independent antigens such as POL and DNP-POL and with antigen- 
antibody complexes (prepared in  a  critical ratio),  the tolerant state has also 
been  successfully  transferred  to  irradiated  recipients  (recently reviewed  by 
Diener  and  Feldmann  [37]).  Moreover,  these investigators have  also  shown 
that removal of cell-bound antigen by trypsinization did not reverse the un- 
responsive state induced by high doses of POL in vitro, provided the period of 
tolerance induction was of sufficient length (37). Our findings with DNP-D-GL 
in  the  present  study  are  quite  consistent  with  these  results  and  provide  a 
strong argument that tolerance among specific B lymphocytes can be, and in its 
absolute sense should be, a reflection of irreversible inhibition of cell reactivity 
to antigen.  Moreover, it is most likely that irreversible inactivation is not a 
unique feature of certain thymus-independent antigens, but pertains to toler- 
ance (in both B and T  cells) in thymus-dependent systems as well. We should 
emphasize, however, that the concept of irreversibility as used here pertains to 
the individual cells which have been exposed to the tolerogen and not neces- 
sarily to the future progeny of the stem cell clone bearing specificity for the 
tolerogen. 
The precise nature of events at the cellular and subcellular levels that result 
in  specific  unresponsiveness  are  as  yet  unknown.  Nonetheless,  as  recently 
reviewed by us (13), certain observations permit the general conclusion to be 
made that the possible interpretation of a given antigenic signal by a specific 
cell,  i.e.  as  a  tolerogenic or  as  an  immunogenic  signal,  will  most  likely be 
determined by the existence of several variables such as  (a)  the density and 
valence of determinant binding at B cell surface receptors, and (b) the presence, 
absence, and/or extent of T  cell regulatory function at the time the signal is 
received. The existence of  tolerance induction  systems  such  as  the  in  vitro 
model developed by Diener and Feldmann and colleagues (37)  and the DNP- 
D-GL model described here may provide certain advantages in studies designed 1426  TOLERANCE  IN  B  LYMPHOCYTES 
to  probe  the  nature  of  subceilular  events  that  follow  transmission  of  the 
tolerogenic signal. 
SUMMARY 
Administration of the 2,4-dinitrophenyl (DNP) derivative of the copolymer 
of D-glutamic acid and D-lysine (D-GL) to inbred mice induces a state of DNP- 
specific tolerance in  such  animals  irrespective of their immune  status  at  the 
time of treatment. Taking advantage of the relative ease with which DNP-D- 
GL can induce tolerance in an animal previously primed with an immunogenic 
DNP-carrier conjugate, we have established conditions for tolerance induction 
in an adoptive cell transfer system. Thus, the adoptive secondary anti-DNP 
antibody response of DNP-keyhole limpet hemocyanin (KLH)-primed spleen 
cells was completely, or almost completely, abolished by exposure of such ceils 
to DNP-D-GL either in vivo or in vitro. Tolerance induction in vivo occurred 
irrespective of whether the DNP-primed cells were exposed to DNP-D-GL in 
the donor animal before adoptive transfer or in recipient mice after transfer. 
In the latter situation, it was possible to show that tolerance induction in this 
model occurs very rapidly (1 hr) and with relatively low doses of tolerogen (50 
/zg).  Incubation  of DNP-KLH-primed cells with  DNP-D-GL in  vitro under 
varFing culture conditions also resulted in depression of the adoptive secondary 
response of such cells,  although the kinetics and degree of tolerance induction 
in this way were slightly different from that obtained by in vivo tolerization. 
Utilizing the adoptive transfer tolerance system, it was possible to approach 
certain questions concerning the mechanism of tolerance induction and fate of 
tolerant bone marrow-derived (B) lymphocytes in the DNP-D-GL model. The 
possibility that suppression of anti-DNP antibody from the DNP-D-GL reflects 
blocking of surface receptor molecules on B  lymphocytes has been ruled out 
by several experimental observations. The most  conclusive evidence on  this 
point derives from the failure of enzymatic treatment with trypsin to reverse 
the tolerant state induced by in vitro exposure of primed cells to DNP-D-GL, 
whereas  trypsinization completely restored the immunocompetence of DNP- 
KLH-primed ceils rendered unresponsive by exposure to DNP-ovalbumin in 
vitro. The present studies also demonstrate that the tolerant state induced by 
DNP-D-GL represents a predominantly irreversible inactivation of specific B 
lymphocytes.  This  conclusion is  derived  from  experiments  in  which  it  was 
found that tolerance was maintained through as many as two serial adoptive 
transfers performed over a period of time of at least 24 days from the single 
exposure of such cells to  the tolerogen. Moreover, the possibility that main- 
tenance  of  tolerance  through  such  serial  transfers was  due  to  inadvertent 
transfer of tolerogenic doses of DNP-D-GL was definitively ruled out. It ap- 
pears,  therefore,  that  DNP-specific  tolerance induced  by DNP-D-GL  is  an 
example of irreversible inhibition of cell reactivity to antigen reflecting yet-to- 
be-determined events at the intra- and subcellular levels. DAVID H.  KATZ, TOSHIYUKI HAMAOKA, BARUJ BENACERRAF  1427 
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